The power of disruptive technological innovation: Transcatheter aortic valve implantation.

about

In vitro 3D model and miRNA drug delivery to target calcific aortic valve disease.

P2860

Q33765102-2522EDF6-EC7D-42DC-AB65-C059C34909DD

P2860

The power of disruptive technological innovation: Transcatheter aortic valve implantation.

Item

http://www.wikidata.org/entity/Q52870899

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

The power of disruptive techno ...... ter aortic valve implantation.

@en

The power of disruptive techno ...... ter aortic valve implantation.

@nl

type

Item

label

The power of disruptive techno ...... ter aortic valve implantation.

@en

The power of disruptive techno ...... ter aortic valve implantation.

@nl

prefLabel

The power of disruptive techno ...... ter aortic valve implantation.

@en

The power of disruptive techno ...... ter aortic valve implantation.

@nl

P1476

The power of disruptive techno ...... ter aortic valve implantation.

@en

P2093

David B Berlin

http://www.w3.org/2001/XMLSchema#string

Frederick J Schoen

http://www.w3.org/2001/XMLSchema#string

Michael J Davidson

http://www.w3.org/2001/XMLSchema#string

P2860

Open versus endovascular stent graft repair of abdominal aortic aneurysms: a meta-analysis of randomized trials

Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial

Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI, April 28-May 2, 1999. Tissue heart valves: current challenges and future research perspectives.

Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.

Survival and long-term outcomes following bioprosthetic vs mechanical aortic valve replacement in patients aged 50 to 69 years.

Choice of prosthetic heart valve for adult patients.

Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.

2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evide

An analysis of real-world cost-effectiveness of TAVI in South Africa

Transcatheter aortic valve implantation: current and future approaches.

P304

1709-1715

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JBM.B.33352

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25545639

http://www.w3.org/2001/XMLSchema#string

The power of disruptive technological innovation: Transcatheter aortic valve implantation.

about

P2860

P2860

The power of disruptive technological innovation: Transcatheter aortic valve implantation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698